Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Fish DNA reference offers hope for food security
Native to northern Africa, Nile tilapia is the most popular species type of farmed fish.

Researchers have developed an entire genome for Nile tilapia. 

A collaboration between the Earlham Institute, WorldFish, and the Roslin Institute - part of the Royal (Dick) School of Veterinary Studies - has produced a “reference genome” for a key fish species that could improve food security for millions of the world’s poorest people.

According to researchers, the fundamental resource will help fish breeders develop strains of the popular type of farmed fish, Nile tilapia, which grow extremely large, very quickly and are resilient to the environmental challenges of global warming. 

Using selective breeding without a complete reference genome, the Genetically Improved Farmed Tilapia (GIFT) programme, led by the research institution WorldFish (CGIAR), has produced an elite strain that is now available worldwide. 

Dr Wilfried Haerty, study author and group leader at the Earlham Institute, explained: “A reference genome provides a full, annotated catalogue of all the genes in an organism. This crucial resource is the basis for modern breeding programmes. WorldFish, who are leading on further developments of GIFT, can now use the reference genome as the baseline to work from when looking to breed beneficial traits.” 

Native to northern Africa, Nile tilapia is the most popular species used in aquaculture. With 4,514,615 t produced in 2020, it is the third most  farmed finfish species worldwide, after grass carp and silver carp.

The GIFT strain was developed through a combination of commercial and wild Nile tilapia strains and crosses with other species.
By examining the genomes of closely related species, researchers were able to show the degree to which genetic material may have been transferred across species in the past - and identify the specific regions in the GIFT genome.

Dr Diego Robledo, aquaculture genetics group leader at the Roslin Institute, said: “The insights offered by development of the entire genome of this key fish species will enable research towards ensuring sustainably produced supplies, to support a healthy source of nutrition for growing populations.”

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.